From Cancer to Immune-Mediated Diseases and Tolerance Induction: Lessons Learned From Immune Oncology and Classical Anti-cancer Treatment
Success in cancer treatment over the last four decades has ranged from improvements in classical drug therapy to immune oncology. Anti-cancer drugs have also often proven beneficial for the treatment of inflammatory and autoimmune diseases. In this review, we report on challenging examples that brid...
Main Authors: | Stephan Klöß, Susann Dehmel, Armin Braun, Michael J. Parnham, Ulrike Köhl, Susanne Schiffmann |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-07-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fimmu.2020.01423/full |
Similar Items
-
Natural Killer Cell-Based Cancer Immunotherapies: From Immune Evasion to Promising Targeted Cellular Therapies
by: Erhard Hofer, et al.
Published: (2017-07-01) -
Low Energy Electron Irradiation Is a Potent Alternative to Gamma Irradiation for the Inactivation of (CAR-)NK-92 Cells in ATMP Manufacturing
by: Lia Walcher, et al.
Published: (2021-06-01) -
Detection of Immune Checkpoint Receptors – A Current Challenge in Clinical Flow Cytometry
by: Benjamin Shibru, et al.
Published: (2021-07-01) -
Editorial: Modulation of Human Immune Parameters by Anticancer Therapies
by: Ulrich Sack, et al.
Published: (2020-12-01) -
Redirected Primary Human Chimeric Antigen Receptor Natural Killer Cells As an “Off-the-Shelf Immunotherapy” for Improvement in Cancer Treatment
by: Olaf Oberschmidt, et al.
Published: (2017-06-01)